The most overbought stocks in the financial sector presents an opportunity to go short on these overvalued companies.

The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70.

Here’s the latest list of major overbought players in this sector.

Forge Global Holdings, Inc. (NYSE:FRGE)

• Forge Global Holdings said it has been added as a member of the U.S. Small-Cap Russell 2000® Index. The company’s stock has a 52-week high of $9.40. .
• RSI Value: 73.42
• FRGE Price Action: Shares of Forge Global rose 2.1% to close at $2.50 on Thursday.

Metalpha Technology Holding Limited (NASDAQ:MATH)

• Metalpha, during April, said it has regained compliance with Nasdaq's minimum bid price requirement. The company’s stock has a 52-week high of $1.42.
• RSI Value: 80.19
• MATH Price Action: Shares of Metalpha Technology gained 7.6% to close at $1.41 on Thursday.

Investors Title Company (NASDAQ:ITIC)

• Investors Title Company reported first-quarter net income of $1.2 million, or 62 cents per diluted share. Chairman J. Allen Fine commented, “The title insurance industry continued to experience economic headwinds in the first quarter. While mortgage rates declined slightly from the prior quarter, the overall higher level continued to negatively impact home sales and commercial real estate activity.” The company has a 52-week high of $168.98.
• RSI Value: 73.28
• ITIC Price Action: Shares of Investors Title Company rose 1.7% to close at $150.01 on Thursday.

Hywin Holdings Ltd. (NASDAQ:HYW)

Coinbase Global, Inc. (NASDAQ:COIN)

• Piper Sandler downgraded the stock from Overweight to Neutral and lowered its price target from $65 to $60. The company has a 52-week high of $116.30.
• RSI Value: 72.14
• COIN Price Action: Shares of Coinbase fell 0.3% to settle at $78.10 on Thursday.

Read More: $40M Bet On MoonLake Immunotherapeutics? Check Out These 3 Stocks Insiders Are Buying